|
 |
|
ORIGINAL ARTICLE |
|
|
|
| Year : 2019 | Volume
: 44
| Issue : 1 | Page : 35-38 |
| |
Effective dose display system in gastric cancer X-ray screening
Kenyu Yamamoto1, Naoko Fujiwara2, Masahiko Kiyama1, Yoshihiro Takeda3, Tadao Kuwano1, Toshizo Katsuda4, Masami Azuma5, Toshinori Ito1
1 Department of Radiology, Osaka Center for Cancer and Cardiovascular Disease Prevention, Osaka, Japan
2 Department of Nursing, Senrikinran University, Suita, Japan
3 Graduate School of Health Sciences, Okayama University, Okayama, Japan
4 Department of Radiology, Butsuryo College of Osaka, Sakai, Osaka, Japan
5 Department of Health Sciences, Osaka Kyoiku University, Kashiwara, Japan
| Date of Submission | 30-Jul-2018 |
| Date of Decision | 18-Dec-2018 |
| Date of Acceptance | 06-Jan-2019 |
| Date of Web Publication | 11-Mar-2019 |
Correspondence Address:
Mr. Kenyu Yamamoto
Department of Radiology, Osaka Center for Cancer and Cardiovascular Disease Prevention, 1-6-107, Morinomiya, Joto-ku, Osaka 536-8588
Japan
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jmp.JMP_78_18
 Abstract | | |
Purpose: The purpose of this study is to build a system for effective dose display immediately after the gastric cancer X-ray screening. Materials and Methods: The regression equation of effective dose and dose area product (DAP) was introduced from the data of 500 persons including DAP and effective dose calculated using program for X-ray Monte Carlo. Results: The effective dose was 5.39 mSv of median, 1.18 mSv of minimum, and 38.38 mSv of maximum. The regression equation was Y=0.354+0.0003772X (Y: effective dose, mSv, X: DAP, mGy cm2). Using the regression equation, the effective dose can be estimated from DAP and displayed just after the individual screening. Conclusions: “Effective dose display system” was constructed to display effective dose immediately after gastric cancer X-ray screening. This system is on the way to be reformed by improving the regression equation on larger data.
Keywords: Dose area product, effective dose, entrance surface dose, gastric cancer X-ray screening, standard radiography
How to cite this article:
Yamamoto K, Fujiwara N, Kiyama M, Takeda Y, Kuwano T, Katsuda T, Azuma M, Ito T. Effective dose display system in gastric cancer X-ray screening. J Med Phys 2019;44:35-8 |
How to cite this URL:
Yamamoto K, Fujiwara N, Kiyama M, Takeda Y, Kuwano T, Katsuda T, Azuma M, Ito T. Effective dose display system in gastric cancer X-ray screening. J Med Phys [serial online] 2019 [cited 2023 Mar 31];44:35-8. Available from: https://www.jmp.org.in/text.asp?2019/44/1/35/253812 |
| Introduction | |  |
On the mortality of cancer, the first place is lung cancer, the second place is colorectal cancer, and the third place is gastric cancer in Japan.[1] The guideline of the Japanese Society of Gastroenterological Cancer Screening (revised edition 2011) recommends population-based screening (Standard radiography I) of 8 images and opportunistic screening (Standard radiography II) of 16 images.[2] High concentrated barium sulfate (>200 w/v%) is recommended as the contrast media in addition to 5.0 g of foaming agent.
The availability of gastric cancer X-ray screening has been reported in some papers,[3],[4] but any disadvantages such as wrong aspiration of barium sulfate [5] and exposure of X-ray radiation [6],[7] are increasing in recent years. There are several reports on the effective dose in gastric cancer X-ray screening until now.[6],[7],[8],[9],[10] The report of Maruyama [6] showed collective effective dose equivalent for 4000 persons and estimated 0.57 mSv of effective dose equivalent with 7 million number of domestic diagnoses in 1991. However, the gastric cancer X-ray screening in 1991 was not Standard radiography. The report [8] showed 3.39 mSv of effective dose by film method using high-density barium sulfate and 3.44 mSv of that by film method using moderate-density barium sulfate. Furthermore, another report [10] showed the values by digital radiography (DR), namely 4.41 mSv by Standard radiography I and 5.15 mSv by Standard radiography II. These values of effective dose were estimated using the standard computer phantom of adult men and women. The calculation of effective dose by the conventional method takes some time, and the value cannot be displayed just after the screening examination. It is only effective dose (mSv) and dose area product (DAP) (mGycm 2) now to display a value.
The aim of this study is to devise the method getting an effective dose display immediately after the gastric cancer X-ray screening. In this study, the regression equation is prepared on the data of (DAP, cGy cm 2) and effective dose obtained by the conventional method. Using the equation, the effective dose can be estimated from measured DAP at once.
| Materials and Methods | | |
The protocol for this study was approved by the Ethical Committee of the Osaka Center for Cancer and Cardiovascular Disease Prevention. This study was partly supported by a KAKENHI Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology (Scientific Research (C) No. 15K08764).
Subjects and methods of X-ray screening
The numbers of the subjects are shown in [Table 1]. In the Osaka Center for Cancer and Cardiovascular Disease Prevention (the Center), the subjects were examined in January 1–November 30, 2013, using Standard radiography I in population-based screening (n = 120) or using Standard radiography II in opportunistic screening (n = 120). The device used in the center was I. I. DR digital X-rays television (TV) fluorography device SREX-D32C Aitella (TOSHIBA Medical Co., Ltd. Tokyo, Japan). The kV and s values were varied and averaged, whereas the mA value was fixed. The average values were 82 kV, 100 mA, and 28 ms. The average value of 82 kV was for 240 people. The beam angulations/projections were not fixed, and the beam angulations/projections changed during gastric cancer X-ray screening. These angulations/projections were averaged in each institution. The center had an average 20 cm + 20 cm of beam angle formation/projection.
In hospital A, the subjects (n = 190) were examined in October 1–December 25, 2014, using original radiography (24 images) in opportunistic screening. The device used in hospital A was flat panel detector (FPD) digital X-rays TV fluorography device ZEXIRA DREX−ZX80 (TOSHIBA Medical Co., Ltd. Tokyo, Japan). The kV and s values were varied and averaged, while the mA value was fixed. The average values were 94 kV, 200 mA, and 17.9 ms. The average value of 94 kV was for 190 people. The beam angulations/projections were not fixed, and the beam angulations/projections changed during gastric cancer X-ray screening. Hospital A had an average 23 cm + 23 cm of beam angle formation/projection.
In hospital B, the subjects (n = 70) were examined in October 1–February 28, 2015, using original radiography (27 images) in opportunistic screening. The device used in hospital B was FPD digital X-rays TV fluorography device SONIAL VISION Safire 17 (Shimadzu Co., Ltd. Kyoto, Japan). Hospital B had an automatic approach with regard to kV, mA, and s values. The average values were 90 kV, 310 mA, and 42.5 ms. The average value of 90 kV was for 70 people. The beam angulations/projections were not fixed, and the beam angulations/projections changed during gastric cancer X-ray screening. Hospital B had on average 18 cm + 24 cm of beam angle formation/projection.
[Table 2] shows the values on X-ray spectrum of TV fluorography device in three facilities. (DAP, cGy cm 2) and entrance surface dose (ESD, mGy, value of the error of measurement 0.1%) of one examination were measured by the area dosimeter of DIAMENTOR M4-KDK (PTW-Freiburg Co. Ltd., Germany).
Regression equation for effective dose and effective dose display system
From the value of DAP, the effective dose was calculated using program for X-ray Monte Carlo (PCXMC) dose calculation ver 2.0.1.3 (STUK-Radiation and Nuclear Safety, Helsinki, Finland) (PCXMC) following the conventional method on the standard computer phantom.
The 163.0 cm and 63.0 kg are the number of screenees in gastric cancer screening. The maximum energy (keV) was 150 keV, and the number of photons was 20000. A scatter diagram was generated for dose-area product (DAP) and the effective dose, and regression analysis was performed on the data to derive the predictive equation (regression equation) for 500 screening events.
Specification changes for Digital Imaging and Communications in Medicine (DICOM) gateway for X-ray TV devices.
DIAMENTOR DICOM MPPS IF is software that adds area dosage and incident dose obtainefrom DIAMENTOR MA-KDK to data of completed testing sent by PDR-03A via DICOM MPPS, and transmits this to RIS.
Additionally, it sets the patient ID, received in inter-process communications from the software on the same PC before starting the testing, to the data after completing testing.
During MPPS, a hospital-designated formula (Y = 0.354 + 0.0003772X) was applied to recalculate the value recorded by an area dosimeter and stored in the tag (0118, 115E), although currently this is performed using a dosimeter.
The system to display effective dose immediately after the end of screening was constructed on a program to calculate effective dose using the regression equation. This system was called “effective dose display system”. The block diagram of this system is shown in [Figure 1].
Statistical analyses
All statistical analyses were performed using PASW Statistics 18 for Windows (IBM SPSS Japan Inc., Tokyo, Japan).
| Results | | |
Regression equation of dose-area product and effective dose
[Table 3] shows the median values of DAP and effective dose based on the subjects of three facilities. The scatter diagram of every DAP and effective dose is shown in [Figure 2]. The equation obtained by regression analysis is as follows and is also written in [Figure 2].
Y=0.354+0.0003772X Y: effective dose (mSv) X: DAP (mGycm 2)
0.354: constant 0.0003772: coefficient
R 2 = 0.996 (P < 0.05)
Effective dose display system
The program enrolled of the regression equation was constructed as calculated effective dose was displayed on screen immediately after screening examination. In the Center, usually DAP, ESD and effective dose of the screening have been displayed on LCD screen after the end of the screening.
For example.
Make DAP the effective dose.
DAP (mGycm2)=12086.8mGycm 2
Y mSv = 0.354+0.0003772X mGycm 2
0.0003772×12086.8 mGycm 2+0.354=4.91314096 mSv
Immediately after the examination, the effective dose is obtained and displayed on the computer screen. An indication screen of the system is shown in [Figure 3]. | Figure 3: Screen shot of gastric cancer X-ray screening effective dose display system
Click here to view |
| Discussion | | |
Since the accident of the nuclear power generation in Fukushima prefecture Japanese people often ask question using effective dose (mSv), the unit of radiation dose. In the center, DAP and ESD are calculated and displayed on PC-LCD screen at the end of the screening examination. However, effective dose has not been displayed as mentioned in the introduction. On the effective dose in gastric cancer X-ray screening, the authors reported in served papers.[8],[9],[10] The values of effective dose in them were calculated using PCXMC software and could not be displayed just after the screening examination. In this study, “effective dose display system” was constructed to display effective dose immediately after gastric cancer screening.
Effective dose is important for a protective unit in X-ray examination. The evaluation of effective dose has been performed using the adult computer phantom of standard men and women according to international commission on radiological protection advice Publication103 year 2007. The value of effective dose is an indicator of radiation on a reference man or woman and not the indicator of actual personal radiation. The risk assessment of radiation for cancer must not be done using effective dose.
As shown in this study, the effective dose can be displayed on PC and informed in response to individual demand. This may relieve the subjects to worry about X-ray dose. However, it is considered to be important that effective dose is explained very carefully, keeping in mind of effective dose on reference person. Until now, similar values of effective dose have been obtained according to the regression equation of this study and the conventional method using PCXMC on standard computer phantom. We work in “effective dose display system.”
The predictive precision of the equation in this study is high in R2 = 0.996. At present, DAP data from many institutions are collected to improve a precision in the regression equation. In near future, effective dose will be calculated using the regression equation on larger data and displayed immediately after gastric cancer X-ray screening.
| Conclusions | | |
The regression equation of DAP and effective dose was introduced on the data of 500 subjects. “effective dose display system” was constructed to display effective dose immediately after gastric cancer X-ray screening.
Acknowledgments
We thank the center deputy director, Kimiko Wada, Also, we are grateful to Yoshiaki Suzuki of Bell Land General Hospital and Yasuyuki Kudo of Higashimatsuyama Municipal Hospital, for data collection.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | | |
| 1. | |
| 2. | A New Stomach Radiography Guideline, Stomach Radiography Standardization Committee. The Japan Society of Gastroenterological Cancer Screening. Tokyo: Medical Review Company; 2011.  |
| 3. | Yamamoto K, Takeda Y, Kuroda C, Kubo T, Kuwano T, Yabunaka K, et al. High concentration barium sulfate used in gastric cancer screening-viscosity change dependent on the volume of artificial gastric juice. Int Fed Med Biomed Eng Proc 2009;25:7-10. |
| 4. | Yamamoto K, Yamazaki H, Kuroda C, Kubo T, Oshima A, Katsuda T, et al. Diagnostic validity of high-density barium sulfate in gastric cancer screening: Follow-up of screenees by record linkage with the Osaka cancer registry. J Epidemiol 2010;20:287-94. |
| 5. | Yamamoto K, Yamazaki H. Prevention of barium sulfate aspiration in gastric cancer screening. J Gastrointest Cancer Screen 2014;52:380-6. |
| 6. | Maruyama T. Frequency and effective dose of the medical radiation exposure. Radiochemistry 1995;38:317-24. |
| 7. | Maruyama T, Iwai K, Nishizawa K, Noda Y, Sumimoto Y. Organ or tissue dose, effective dose and collective effective dose from X-ray diagnosis, in Japan. Radioisotopes 1996;45:761-73. |
| 8. | Yamamoto K, Azuma M, Kuroda C, Kubo T, Yabunaka K, Yamazaki H, et al. Radiation dose in mass screening for gastric cancer with high-concentration barium sulfate compared with moderate-concentration barium sulfate. Australas Phys Eng Sci Med 2009;32:88-91. |
| 9. | Yamamoto K, Yamazaki H, Takakura R, Ogawa T, Kuwano T, Miura K, et al. Effective dose on examinees of X-ray screening for gastric cancer -I.I.DR. Digital radiography. J Gastrointest Cancer Screen 2015;53:365-75. |
| 10. | Yamamoto K, Kuroda C, Takeda Y, Toshizo K, Yamazaki H, Kuwano T, et al. The estimation of effective dose in gastric cancer screening using lead acrylic filters. Mem Osaka Kyoiku Univ Ser 2011;59:19-23. |
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3]
| This article has been cited by | | 1 |
Medical image recognition and segmentation of pathological slices of gastric cancer based on Deeplab v3+ neural network |
|
| Jing Wang, Xiuping Liu | | Computer Methods and Programs in Biomedicine. 2021; 207: 106210 | | [Pubmed] | [DOI] | |
|
|
|
|
